Cargando…
Antibody-Mediated Oligodendrocyte Remyelination Promotes Axon Health in Progressive Demyelinating Disease
Demyelination underlies early neurological symptoms in multiple sclerosis (MS); however, axonal damage is considered critical for permanent chronic deficits. The precise mechanisms by which axonal injury occurs in MS are unclear; one hypothesis is the absence or failure of remyelination, suggesting...
Autores principales: | Wootla, Bharath, Denic, Aleksandar, Watzlawik, Jens O., Warrington, Arthur E., Rodriguez, Moses |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5012151/ https://www.ncbi.nlm.nih.gov/pubmed/26409478 http://dx.doi.org/10.1007/s12035-015-9436-3 |
Ejemplares similares
-
A monoclonal natural human IgM protects axons in the absence of remyelination
por: Wootla, Bharath, et al.
Publicado: (2016) -
A single dose of a neuron-binding human monoclonal antibody improves brainstem NAA concentrations, a biomarker for density of spinal cord axons, in a model of progressive multiple sclerosis
por: Wootla, Bharath, et al.
Publicado: (2015) -
PDGF is Required for Remyelination-Promoting IgM Stimulation of Oligodendrocyte Progenitor Cell Proliferation
por: Watzlawik, Jens O., et al.
Publicado: (2013) -
Human class I major histocompatibility complex alleles determine central nervous system injury versus repair
por: Wootla, Bharath, et al.
Publicado: (2016) -
Antibody Binding Specificity for Kappa (Vκ) Light Chain-containing Human (IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study
por: Watzlawik, Jens O., et al.
Publicado: (2016)